Search

everythinglearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Alopecia areata involves immune response and gene changes affecting hair loss.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Transplant success has improved with better immunosuppressive drugs and donor matching.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.